Enhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus casei
- PMID: 25041982
- DOI: 10.1002/jps.24083
Enhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus casei
Abstract
Bacteria of micrometer size could accumulate in tumor based on enhanced permeability and retention (EPR) effect. We report here Lactobacillus casei (L. casei), a nonpathogenic facultatively anaerobic bacterium, preferentially accumulated in tumor tissues after intravenously (i.v.) injection; at 24 h, live bacteria were found more in the tumor, whereas the bacteria in normal tissues including the liver and spleen were cleared rapidly. The tumor-selective accumulation and growth of L. casei is probably due to the EPR effect and the hypoxic tumor environment. Moreover, the bacterial tumor delivery was significantly increased by a nitric oxide (NO) donor nitroglycerin (NG, 10-70 times) and an angiotensin II converting enzyme inhibitor, enalapril (6-18 times). Consequently significant suppression of tumor growth was found in a colon cancer C26 model, and more remarkable antitumor effect was achieved when L. casei was combined with NG, probably by modulating the host nonspecific immune responses; tumor necrosis factor-α significantly increased in tumor after the treatment, as well as NO synthase activity and myleoperoxidase activity. These findings suggest the potential of L. casei as a candidate for targeted bacterial antitumor therapy, especially in combine with NG or other vascular mediators.
Keywords: ACE inhibitor; Cancer; Distribution; EPR effect; Lactobacillus casei; Nanotechnology; Permeability; Targeted drug delivery; nitroglycerin; vascular permeability.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.
Similar articles
-
Enhancement of Tumor-Targeted Delivery of Bacteria with Nitroglycerin Involving Augmentation of the EPR Effect.Methods Mol Biol. 2016;1409:9-23. doi: 10.1007/978-1-4939-3515-4_2. Methods Mol Biol. 2016. PMID: 26846798
-
Treatment with Lactobacillus Retards the Tumor Growth of Head and Neck Squamous Cell Carcinoma Cells Inoculated in Mice.Tohoku J Exp Med. 2018 Aug;245(4):269-275. doi: 10.1620/tjem.245.269. Tohoku J Exp Med. 2018. PMID: 30158369
-
Lactobacillus casei Ghosts as a Vehicle for the Delivery of DNA Vaccines Mediate Immune Responses.Front Immunol. 2022 May 31;13:849409. doi: 10.3389/fimmu.2022.849409. eCollection 2022. Front Immunol. 2022. PMID: 35711427 Free PMC article.
-
Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(3):53-71. doi: 10.2183/pjab.88.53. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 22450535 Free PMC article. Review.
-
A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.Microcirculation. 2016 Apr;23(3):173-82. doi: 10.1111/micc.12228. Microcirculation. 2016. PMID: 26237291 Review.
Cited by
-
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria.Pharmaceutics. 2023 Jul 21;15(7):2004. doi: 10.3390/pharmaceutics15072004. Pharmaceutics. 2023. PMID: 37514190 Free PMC article. Review.
-
Improved In Vivo Delivery of Small RNA Based on the Calcium Phosphate Method.J Pers Med. 2021 Nov 8;11(11):1160. doi: 10.3390/jpm11111160. J Pers Med. 2021. PMID: 34834512 Free PMC article.
-
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment.J Pers Med. 2021 Jun 18;11(6):571. doi: 10.3390/jpm11060571. J Pers Med. 2021. PMID: 34207137 Free PMC article. Review.
-
In Situ Delivery and Production System (iDPS) of Anti-Cancer Molecules with Gene-Engineered Bifidobacterium.J Pers Med. 2021 Jun 17;11(6):566. doi: 10.3390/jpm11060566. J Pers Med. 2021. PMID: 34204302 Free PMC article. Review.
-
Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer.Cancers (Basel). 2020 Jul 13;12(7):1881. doi: 10.3390/cancers12071881. Cancers (Basel). 2020. PMID: 32668616 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous